正在建设中
Under Construction

苏州大学附属第四医院肿瘤科等①与苏州赛默医学检验实验室②合作报道了替莫唑胺通过激活ERK信号通路促进MGMT转录从而导致恶性黑色素瘤的化疗耐药,文章发表在Joumal of cellular and molecular medicine.

Temozolomide-Promoted MGMT Transcription Contributes to Chemoresistance by Activating the ERK Signalling Pathway in Malignant Melanoma.